Agenda
Tuesday November 21, 2006 9:30 a.m. HHR B

Work Session:  Follow-up on Genetically Engineered Organisms (GEOs) and Biotechnology - Focus on Life Sciences.

1. Welcome and Introductions.
2. Overview of the Life Sciences Sector in Washington State. 
   • Dr. Lee Huntsman, Executive Director, Life Science Discovery Fund. 
     Overview of the life sciences and biomedical sector in Washington with an update on the  status of the Life Sciences Discovery Fund.
   • Dr. Jack Faris, Ph.D., President, Washington Biotechnology and Biomedical Association. 
     Industry overview of the growth of the life sciences and biomedical technology sector in  Washington and overview of WBBA's Comprehensive Bioscience Strategy for   Washington's Future and key public policy issues related to the strategy.
3. The Science of Stem Cell Research and Key Policy Considerations.
• Dr. Charles Murry, M.D., Ph.D., Director, Center for Cardiovascular Biology and Regenerative Medicine, University of Washington.
  The science of stem cell research and harnessing the potential of adult and embryonic  stem cells to regenerate cardiac muscles and coronary circulation.
• Anna C. Mastroianni, Associate Professor of Law and Public Health Genetics, University of Washington.
  Ethical and policy considerations in embryonic stem cell research. Also, Prof.   Mastroianni will highlight some of the key decision points and rationales for state  policymaking in this area and the relevance of ethics to these decisions.
4. Case Study: California Institute for Regenerative Medicine.
   • Dr. Zack Hall, President, California Institute for Regenerative Medicine. 
     Overview of the California Institute for Regenerative Medicine.  How the institute is  reconciling an aggressive state policy with federal law and how the institute will monitor  grants or loans awarded to private entities with off-shore operations.
5. Intellectual Property: Who owns the Breakthroughs?
   • Sean O'Connor, Associate Professor, University of Washington School of Law and  Associate Director, Center for Advanced Study & Research on Intellectual Property.
      Intellectual property rights related to life science and genetically engineered organisms.